Table 3.
Rank | Inclusion Criterion Pattern | Study Coverage # of Studies (%) | Exclusion Criterion Pattern | Study Coverage # of Studies (%) |
N = 57 | N = 57 | |||
1 | Aspartate aminotransferase (AST) | 32 (56.14%) | Unstable angina | 36 (63.16%) |
2 | Measurable disease | 29 (50.88%) | Myocardial infarction | 34 (59.65%) |
3 | Age | 29 (50.88%) | Radiotherapy | 30 (52.63%) |
4 | Absolute neutrophil count | 29 (50.88%) | Congestive heart failure | 26 (45.61%) |
5 | Platelets | 27 (47.36%) | Pregnant | 22 (38.60%) |
6 | Metastatic colorectal cancer | 27 (47.36%) | Bone fracture | 22 (38.60%) |
7 | Hemoglobin | 25 (43.86%) | Significant traumatic injury | 22 (38.60%) |
8 | Bilirubin | 22 (38.60%) | Bleeding diathesis | 21 (36.84%) |
9 | Creatinine | 22 (38.60%) | Chemotherapy | 20 (35.09%) |
10 | Alanine transaminase (ALT) | 20 (35.09%) | Skin ulcers | 20 (35.09%) |